Aurora Cannabis (NASDAQ:ACB) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPS

Aurora Cannabis (NASDAQ:ACB) announced its earnings results on Wednesday. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a negative net margin of 17.47% and a negative return on equity of 2.19%.

Aurora Cannabis Price Performance

Shares of ACB traded up $1.84 during midday trading on Wednesday, hitting $5.52. The company’s stock had a trading volume of 42,119,729 shares, compared to its average volume of 2,240,929. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a one year low of $2.84 and a one year high of $9.35. The stock has a market capitalization of $302.72 million, a price-to-earnings ratio of -7.21 and a beta of 1.85. The company’s fifty day simple moving average is $4.19 and its two-hundred day simple moving average is $5.16.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. TD Cowen started coverage on Aurora Cannabis in a research report on Wednesday, December 11th. They set a “buy” rating on the stock.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.